Skip to content

Assays and Diagnostics

Speeding the time-to-clinic with Optimer®

New research shows how Optimer can speed projects by up to 75% compared to standard antibodies. Speeding project timelines can be vital to the development of any life science product. Whether…

Expanding proteomic capabilities with Optimers

The genomic revolution brought simple, sensitive and rapid DNA sequencing, creating a step-change in our biological understanding. Next-generation proteomics is now promising to do the same for protein sequencing…

New methods for hapten bioanalysis

Anti-hapten antibodies are difficult and slow to generate limiting cheap and efficient bioanalysis in this field. Our proprietary methods offer standard assay formats, such as ELISA and lateral flow…

Anti-hapten antibody production problems

Why are haptens such a hard-to-solve target class for antibody development? Small molecules are ubiquitous in our environment. They cover hormones and toxins to drugs and vitamins. There is an…